Clostridium Difficile

Microbiome upstart Vedanta gets an extra $18.5M in the bank, wrapping up $45.5 series C round
Endpoints
Mon, 05/13/19 - 10:03 am
microbiome
Vedanta Biosciences
VE303
Clostridium Difficile
FDA delays decision on Merck's C. diff drug
BioPharma Dive
Tue, 07/26/16 - 11:03 am
FDA
Merck
Clostridium Difficile
bezlotoxumab
monoclonal antibodies
Merck faces FDA delay for C. diff antibody amid trial data concerns
Fierce Biotech
Fri, 07/22/16 - 09:36 am
Merck
FDA
Clostridium Difficile
clinical trials
bezlotoxumab
Seres Therapeutics To Conduct First Clinical Trial Of Synthetic Microbiome Drug
Xtalks
Fri, 07/8/16 - 11:20 am
Seres Therapeutics
clinical trials
SER-262
microbiome
Clostridium Difficile
Pfizer’s Investigational Vaccine Candidate for Clostridium difficile Receives U.S. Food and Drug Administration Fast Track Desig
Marketwatch
Thu, 08/28/14 - 10:02 am
FDA
Pfizer
vaccine
Clostridium Difficile
Deadly Bowel Infection Draws Drugmakers Seeking Cures
Bloomberg
Mon, 04/14/14 - 08:37 am
Merck
Sanofi
Actelion
Shire
Clostridium Difficile
Sanofi Pasteur Initiates Phase III Study of Investigational Clostridium difficile Vaccine in the United States
Yahoo
Mon, 08/5/13 - 09:36 am
Clostridium Difficile
Sanofi Pasteur
Cdiffense
vaccines
Actelion Drug to Move into Phase III
Yahoo/Zacks
Wed, 12/26/12 - 09:24 pm
Actelion
cadazolid
Clostridium Difficile
Optimer Earns Milestone Payment
Yahoo/Zacks
Sat, 06/9/12 - 12:19 pm
Optimer
Dificlir
Clostridium Difficile
antibiotics
New Data Demonstrates DIFICLIR™ May Offer Benefits for Cancer Patients, who are at High Risk of Clostridium Difficile Infection
Sacramento Bee, CA
Sat, 03/31/12 - 01:03 pm
Dificid
Clostridium Difficile
Astellas
FDA says ulcer drugs may raise diarrhea risk
Reuters
Wed, 02/8/12 - 11:48 am
diarrhea
FDA
Nexium
Clostridium Difficile
Optimer's DIFICID provides economic value in the treatment of CDAD
Yahoo/Fly on the Wall
Tue, 12/6/11 - 11:15 am
Dificid
Optimer
Clostridium Difficile
Cubist plans late-stage studies of diarrhea drug
Yahoo/AP
Fri, 09/30/11 - 11:00 am
Cubist
diarrhea
CB-183
315
Clostridium Difficile
CHMP Recommends Astellas Pharma Europe Ltd.'s (APEL) DIFICLIR for Approval in the EU
Yahoo/PR NewsWire
Sat, 09/24/11 - 12:40 pm
Optimer Pharmaceuticals
Astellas
Dificlir
Clostridium Difficile
fidaxomicin
Bullish on Optimer Pharma
Yahoo/Zacks.com
Tue, 08/16/11 - 08:22 am
Optimer
antibiotics
Dificid
Clostridium Difficile
Cubist Pharmaceuticals
ViroPharma
Optimer Launches Dificid
Yahoo/Zacks.com
Wed, 07/20/11 - 06:48 pm
Optimer
Dificid
Cubist Pharmaceuticals
Clostridium Difficile
antibiotics
Cubist might stay clear of Ph3 for antibiotic, analyst says
Fierce Biotech
Fri, 06/17/11 - 12:39 pm
antibiotics
Cubist Pharmaceuticals
Clostridium Difficile
Optimer Prices New Antibiotic at Premium
TheStreet.com
Tue, 05/31/11 - 12:37 pm
Optimer
antibiotics
drug pricing
Dificid
Clostridium Difficile
Optimer climbs in pre-market trading and company readies launch of first FDA-approved drug
Yahoo/AP
Tue, 05/31/11 - 09:22 am
FDA
Optimer
antibiotics
Clostridium Difficile
Dificid
FDA Approves Optimer's DIFICID (fidaxomicin) Tablets for the Treatment of Patients with Clostridium difficile-Associated Diarrhea (CDAD)
Yahoo/PR NewsWire
Sat, 05/28/11 - 12:01 pm
Clostridium Difficile
C. difficile
Optimer
Dificid

Pages